Global Longlife Hospital and Research Ltd Financials
Company Logo

Global Longlife Hospital and Research Ltd Financial Statement

Global Longlife Hospital and Research Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2023
Revenue11.87
Operating Expense9.44
Net Profit1.07
Net Profit Margin9.01
Earning Per Share1.05
EBIDTA2.14
Effective Tax Rate11.52

Global Longlife Hospital and Research Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual0.58
Operating Expenses Annual4.74
Operating Profit Annual0.86
Interest Annual0.28
Depreciation0.48
Net Profit Annual0.20
Tax Annual-0.10

Global Longlife Hospital and Research Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.39
Cash Flow from Operations12.32
Cash Flow from Investing21.80
Cash Flow from Financing-13.01
Cash Flow at the End21.49

Global Longlife Hospital and Research Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)-689.66
PBIT Margin (%)-772.41
PBT Margin (%)1,801.73
Net PROFIT Margin (%)34.48
Return On Networth / Equity (%)-17.04
Return On Networth /Employed (%)-13.27
Return On Assets (%)0.69
Total Debt / Equity (X)0.24
Asset Turnover Ratio (%)0.02

Global Longlife Hospital and Research Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets AnnualTBA
Total Current Assets Annual22.64
Non Current Assets Annual4.21
Total Shareholders Funds Annual26.79
Total Assets Annual26.84

Global Longlife Hospital and Research Ltd Earning Calls

No Data Availabe

FAQS on Global Longlife Hospital and Research Ltd Financials

As of Aug 17, 2025, Global Longlife Hospital and Research Ltd has a market capitalization of 19.91 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Global Longlife Hospital and Research Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , Global Longlife Hospital and Research Ltd recorded a total revenue of approximately 0.58 Cr marking a significant milestone in the company's financial performance.

Global Longlife Hospital and Research Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.4% and -1.8% annually, respectively..

Global Longlife Hospital and Research Ltd's current PE ratio is 99.55.

Global Longlife Hospital and Research Ltd's ROCE averaged 0.6% from the FY ending March 2023 to 2025, with a median of 1.4%. It peaked at 4.2% in March 2023, reflecting strong capital efficiency over the period..

Global Longlife Hospital and Research Ltd's latest EBIT is Rs. 0.38 Cr, surpassing the average EBIT of Rs. 0.66 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions